T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Iridium Communications
IRDM
$5.26B
| $615K | ﹤0.01% |
26,442
-1,426,668
| -98% | -$35.5M |
|
2027
Vicor
VICR
$10.4B
| $615K | ﹤0.01% |
19,821
| – | – |
|
|
GPOR
2028
DELISTED
Gulfport Energy Corp.
GPOR
| $615K | ﹤0.01% |
125,248
+7,600
| +6% | +$48.4K |
|
2029
TTM Technologies
TTMI
$14.5B
| $613K | ﹤0.01% |
60,116
+639
| +1% | +$7.08K |
|
2030
Tennant Co
TNC
$1.18B
| $611K | ﹤0.01% |
9,978
-4,853
| -33% | -$303K |
|
2031
Hackett Group
HCKT
$278M
| $610K | ﹤0.01% |
36,345
+5,200
| +17% | +$83.9K |
|
2032
3D Systems Corp
DDD
$603M
| $609K | ﹤0.01% |
66,957
+476
| +0.7% | +$4.51K |
|
2033
Movado Group
MOV
$815M
| $609K | ﹤0.01% |
22,553
| – | – |
|
2034
German American Bancorp
GABC
$1.91B
| $608K | ﹤0.01% |
20,192
+37
| +0.2% | +$1.09K |
|
|
NCI
2035
DELISTED
Navigant Consulting, Inc.
NCI
| $608K | ﹤0.01% |
26,236
-968,884
| -97% | -$21.4M |
|
2036
Extreme Networks
EXTR
$3.2B
| $607K | ﹤0.01% |
93,791
+331
| +0.4% | +$2.19K |
|
2037
Fortis
FTS
$28.7B
| $607K | ﹤0.01% |
15,340
-369
| -2% | -$14K |
|
2038
AutoNation
AN
$6.9B
| $606K | ﹤0.01% |
14,460
+14
| +0.1% | +$557 |
|
|
LMNX
2039
DELISTED
Luminex Corp
LMNX
| $602K | ﹤0.01% |
29,149
+29
| +0.1% | +$637 |
|
|
BHR
2040
Braemar Hotels & Resorts
BHR
$139M
| $601K | ﹤0.01% |
61,290
+6,363
| +12% | +$75.5K |
|
2041
Methode Electronics
MEI
$602M
| $599K | ﹤0.01% |
20,976
-51,411
| -71% | -$1.44M |
|
2042
Moelis & Co
MC
$4.91B
| $597K | ﹤0.01% |
17,091
+168
| +1% | +$6.08K |
|
2043
Tootsie Roll Industries
TR
$3.05B
| $597K | ﹤0.01% |
19,875
+35
| +0.2% | +$1.1K |
|
|
AMJ
2044
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $593K | ﹤0.01% |
23,600
-5,000
| -17% | -$126K |
|
2045
Asbury Automotive
ABG
$3.76B
| $590K | ﹤0.01% |
7,000
+37
| +0.5% | +$2.89K |
|
2046
First Business Financial Services
FBIZ
$593M
| $588K | ﹤0.01% |
25,039
+425
| +2% | +$9.65K |
|
2047
Newmark Group
NMRK
$2.68B
| $586K | ﹤0.01% |
65,203
+300
| +0.5% | +$2.53K |
|
|
TUP
2048
DELISTED
Tupperware Brands Corporation
TUP
| $585K | ﹤0.01% |
30,758
+100
| +0.3% | +$2.25K |
|
|
RVI
2049
DELISTED
Retail Value Inc. Common Shares
RVI
| $583K | ﹤0.01% |
182,438
+1,046
| +0.6% | +$3.21K |
|
2050
Greif
GEF
$5B
| $581K | ﹤0.01% |
17,839
+126
| +0.7% | +$4.69K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.